Bumper Offer - Urjas oil Just @ Rs. 1
Rosumac ASP 20 Capsule is a prescription medicine that is available as a Capsule. Other than this, Rosumac ASP 20 Capsule has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Rosumac ASP 20 Capsule depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
While these are the most often observed Rosumac ASP 20 Capsule side effects, there are can be others also. These have been listed below. Usually, these side effects of Rosumac ASP 20 Capsule go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Rosumac ASP 20 Capsule has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Rosumac ASP 20 Capsule's effects on the liver, heart and kidney, if any, have been listed below.
Rosumac ASP 20 Capsule is contraindicated in people with pre-existing medical conditions like Kidney Disease, Hypothyroidism, Drug Allergy as it can result in adverse effects. The section on Rosumac ASP 20 Capsule contraindications lists all such conditions.
Drug reaction of Rosumac ASP 20 Capsule with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Rosumac ASP 20 Capsule is considered safe while driving, and is addictive.
Rosumac ASP 20 Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Rosumac ASP 20 Capsule is used -
Severe
Moderate
Mild
Is the use of Rosumac ASP 20 Capsule safe for pregnant women?
Rosumac ASP should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Rosumac ASP 20 Capsule safe during breastfeeding?
Taking Rosumac ASP may lead to serious side effects if you are breastfeeding. Rosumac ASP should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Rosumac ASP 20 Capsule on the Kidneys?
Rosumac ASP can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Rosumac ASP 20 Capsule on the Liver?
Rosumac ASP is completely safe for the liver.
What is the effect of Rosumac ASP 20 Capsule on the Heart?
There may be an adverse effect on the heart after taking Rosumac ASP. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Rosumac ASP 20 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Rosumac ASP 20 Capsule unless your doctor advises you to do so -
Is this Rosumac ASP 20 Capsule habit forming or addictive?
Rosumac ASP 20 Capsule does not cause addiction.
Interaction between Food and Rosumac ASP 20 Capsule
There isn't any research available on the side effects of taking Rosumac ASP 20 Capsule with food.
Interaction between Alcohol and Rosumac ASP 20 Capsule
It is difficult to say anything about the effect of Rosumac ASP 20 Capsule and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194